Skip to main content
SpringerLink
Log in

Andropause: Need for concrete guidelines until more evidence becomes available

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liu PY, Swerdloff RS, Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 2004, 89: 4789–96.

    Article  CAS  PubMed  Google Scholar 

  2. Griffin JE, Wilson JD. Disorders of the testes and the male reproductive tract. In: Wilson, Foster, Kronenberg, Larsen eds: Williams Textbook of Endocrinology, 9th ed. Philadelphia: W.B. Saunders. 1998, 819–75.

    Google Scholar 

  3. Christiansen K. Behavioural correlates of testosterone. In: Nieschlag E, Behre HM eds: Testosterone: Action, deficiency and substitution. 2nd ed. Berlin: Springer-Verlag. 1998, 107–42.

    Chapter  Google Scholar 

  4. Vermeulen A. Androgen replacement therapy in the aging male—a critical evaluation. J Clin Endocrinol Metab 2001, 86: 2380–90.

    CAS  PubMed  Google Scholar 

  5. Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004, 89: 3813–7.

    Article  CAS  PubMed  Google Scholar 

  6. Bhasin S. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clin Proc 2000, 75 (Suppl): S70–5.

    CAS  PubMed  Google Scholar 

  7. Araujo AB, O’donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the massachusetts male aging study. J Clin Endocrinol Metab 2004, 89: 5920–6.

    Article  CAS  PubMed  Google Scholar 

  8. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999, 84: 1966–72.

    CAS  PubMed  Google Scholar 

  9. Amory JK, Watts NB, Easley KA, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004, 89: 503–10.

    Article  CAS  PubMed  Google Scholar 

  10. Bhasin S, Woodhouse L, Casaburi R, et al. Older Men are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle. J Clin Endocrinol Metab 2005, 90: 678–88.

    Article  CAS  PubMed  Google Scholar 

  11. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005, 90: 1502–10.

    Article  CAS  PubMed  Google Scholar 

  12. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002, 5: 74–86.

    Article  CAS  PubMed  Google Scholar 

  13. Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med 2001, 110: 563–72.

    Article  CAS  PubMed  Google Scholar 

  14. Rubens R, Dhont M, Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1974, 39: 40–5.

    Article  CAS  PubMed  Google Scholar 

  15. Mitchell R, Hollis S, Rothwell C, Robertson WR. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin Endocrinol (Oxf) 1995, 42: 501–7.

    Article  CAS  Google Scholar 

  16. Mulligan T, Iranmanesh A, Gheorghiu S, et al. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling—a clinical research center study. J Clin Endocrinol Metab 1995, 80: 3025–31.

    CAS  PubMed  Google Scholar 

  17. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983, 56: 1278–81.

    Article  CAS  PubMed  Google Scholar 

  18. Diver MJ, Imtiaz KE, Ahmad AM, et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003, 58: 710–7.

    Article  CAS  Google Scholar 

  19. Elin RJ, Winters SJ. Current controversies in testosterone testing: aging and obesity. Clin Lab Med 2004, 24: 119–39.

    Article  PubMed  Google Scholar 

  20. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994, 79: 997–1000.

    CAS  PubMed  Google Scholar 

  21. Christ-Crain M, Meier C, Huber PR, et al. Value of GnRH Testing in the Differential Diagnosis of Androgen Deficiency in Elderly Men. J Clin Endocrinol Metab 2005, 90: 1280–6.

    Article  CAS  PubMed  Google Scholar 

  22. Citron JT, Ettinger B, Rubinoff H, et al. Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. J Urol 1996, 155: 529–33.

    Article  CAS  PubMed  Google Scholar 

  23. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994, 14: 701–6.

    Article  CAS  PubMed  Google Scholar 

  24. Webb CM, McNeill JG, Hayward CS, et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999, 100: 1690–6.

    Article  CAS  PubMed  Google Scholar 

  25. Rosano GM, Leonardo F, Pagnotta P, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999, 99: 1666–70.

    Article  CAS  PubMed  Google Scholar 

  26. Malkin CJ, Pugh PJ, Jones RD, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004, 89: 3313–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, 4940 Eastern Avenue, Suite B-114, Baltimore, MD, 21224, USA

    S. Basaria MD

Authors
  1. S. Basaria MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Basaria MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basaria, S. Andropause: Need for concrete guidelines until more evidence becomes available. J Endocrinol Invest 28, 667–670 (2005). https://doi.org/10.1007/BF03347269

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347269

Key-words

Search

Navigation